Home
  • home
  • boards
  • job center
  • news archives
  • chat
  • networking
  • overheard
  • pharmagather
  • advertise
  • contact us





  • cafepharma news hand selected daily
  • get news headlines in your inbox each weekday
Home

denosumab

Tagged:  
  • Amgen
  • denosumab
  • FDA
  • Prolia
Amgen's Denosumab Turned Down Again, but It May Not Be as Bad as It Seems
BNET Pharma
  • Login or register to post comments
Tagged:  
  • Amgen
  • denosumab
  • FDA
  • Prolia
FDA requests additional studies for Amgen drug
Marketwatch
  • Login or register to post comments
Tagged:  
  • Amgen
  • denosumab
  • Prolia
Never Mind The Delay, Amgen Puts D'mab on its Website
InVivo
  • Login or register to post comments
Tagged:  
  • Amgen
  • denosumab
  • FDA
  • osteoporosis
  • Prolia
Amgen's Denosumab Delay Not a Deal-Breaker; Cancer Remains the Big Question
BNET Pharma
  • Login or register to post comments
Tagged:  
  • Amgen
  • denosumab
  • osteoporosis
  • Prolia
Amgen: Still Waiting for Its Blockbuster
Motley Fool
  • Login or register to post comments
Tagged:  
  • Amgen
  • denosumab
  • GSK
  • Novartis
Good News for Top of AMGN's Pipeline
Yahoo/Zacks.com
  • Login or register to post comments
Tagged:  
  • Amgen
  • cancer
  • denosumab
  • Novartis
  • Zometa
Amgen reports results of trial of cancer treatment
Marketwatch
  • Login or register to post comments
Tagged:  
  • Amgen
  • denosumab
  • Fablyn
  • osteoporosis
  • Pfizer
  • Viviant
  • Wyeth
From the Osteoporosis Front, Updates on Potential New Drugs
WSJ Online
  • Login or register to post comments
Tagged:  
  • Amgen
  • denosumab
  • Novartis
  • rheumatoid arthritis
Another Positive Indication for Amgen's Denosumab
Seeking Alpha
  • Login or register to post comments
Tagged:  
  • Amgen
  • denosumab
At Amgen, a Prescription for Success
Barron's
  • Login or register to post comments
123next ›last »
Syndicate content

News Tags

Abbott Amgen Amylin Astra Zeneca Biogen biotech Bristol-Myers Squibb buyouts cancer Dendreon diabetes drug trials earnings Elan Eli Lilly FDA Genentech generics Genzyme Gilead GSK H1N1 healthcare reform JNJ Johnson and Johnson layoffs Lilly M&A Merck MS Novartis patents Pfizer Roche Sanofi-Aventis Schering-Plough swine flu Teva vaccines Wyeth
more tags

New on Cafepharma

  • Funny or interesting conversations reps hear in the field
    Overheard in the Field
  • Keep up with the latest at cafepharma:
    follow us on twitter
  • GE Healthcare IT
  • HIV Reps
  • New message boards
    Baxter IT
  • Pacific Pulmonary Services
  • Pacific Pulmonary Services IT
  • New message board category
    Pharma IT Boards



user login

  • Create new account
  • Request new password